Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R T D Oliver

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Surgical Oncology|March 10, 2009
Intermittent hormone therapy and its place in the contemporary endocrine treatment of prostate cancerG Shaw, R T D Oliver
Cancer Biology & Therapy|April 4, 2003
Post-biopsy rise in serum PSA. A potential tool for the dynamic evaluation of prostate cancer/prostatic intraepithelial neoplasia (PIN)Shiv Bhanot, R Gopalakrishnan, R T D Oliver
Prostate Cancer and Prostatic Diseases|December 24, 2002
Influence of circumcision and sexual behaviour on PSA levels in patients attending a sexually transmitted disease (STD) clinicJ C Oliver, R T D Oliver, R C Ballard
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 26, 2008
Long-term follow-up of testicular cancer patients shows no predisposition to osteoporosisN Murugaesu, T Powles, J Bestwick, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Potential of intermittent hormone therapy for M+ and M0 prostate cancer patientsR T D Oliver, D Farrugia, W Ansell, et al.
British Journal of Cancer|September 19, 2002
DNA topoisomerase I and II expression in drug resistant germ cell tumoursD M Berney, J Shamash, J Gaffney, et al.
Urologia Internationalis|January 23, 2002
Comparative study between direct mild acid extraction and immunobead purification technique for isolation of HLA class I-associated peptidesN Torabi-Pour, A M E Nouri, R Saffie, et al.
Urologia Internationalis|March 29, 2002
Comparative study of peptides isolated from class I antigen groove of urological specimens. a further step toward the future of peptide therapy in bladder cancer patientsN Torabi-Pour, A M E Nouri, R Saffie, et al.
British Journal of Cancer|December 1, 2004
Chlorambucil and lomustine (CL56) in absolute hormone refractory prostate cancer: re-induction of endocrine sensitivity an unexpected findingJ Shamash, G Dancey, C Barlow, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 20, 2003
Testis conserving chemotherapy in germ cell cancer: its potential to increase understanding of the biology and treatment of carcinoma-in-situR T D Oliver, J Ong, D Berney, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Surgical Oncology|March 10, 2009
Intermittent hormone therapy and its place in the contemporary endocrine treatment of prostate cancerG Shaw, R T D Oliver
Cancer Biology & Therapy|April 4, 2003
Post-biopsy rise in serum PSA. A potential tool for the dynamic evaluation of prostate cancer/prostatic intraepithelial neoplasia (PIN)Shiv Bhanot, R Gopalakrishnan, R T D Oliver
Prostate Cancer and Prostatic Diseases|December 24, 2002
Influence of circumcision and sexual behaviour on PSA levels in patients attending a sexually transmitted disease (STD) clinicJ C Oliver, R T D Oliver, R C Ballard
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 26, 2008
Long-term follow-up of testicular cancer patients shows no predisposition to osteoporosisN Murugaesu, T Powles, J Bestwick, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Potential of intermittent hormone therapy for M+ and M0 prostate cancer patientsR T D Oliver, D Farrugia, W Ansell, et al.
British Journal of Cancer|September 19, 2002
DNA topoisomerase I and II expression in drug resistant germ cell tumoursD M Berney, J Shamash, J Gaffney, et al.
Urologia Internationalis|January 23, 2002
Comparative study between direct mild acid extraction and immunobead purification technique for isolation of HLA class I-associated peptidesN Torabi-Pour, A M E Nouri, R Saffie, et al.
Urologia Internationalis|March 29, 2002
Comparative study of peptides isolated from class I antigen groove of urological specimens. a further step toward the future of peptide therapy in bladder cancer patientsN Torabi-Pour, A M E Nouri, R Saffie, et al.
British Journal of Cancer|December 1, 2004
Chlorambucil and lomustine (CL56) in absolute hormone refractory prostate cancer: re-induction of endocrine sensitivity an unexpected findingJ Shamash, G Dancey, C Barlow, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 20, 2003
Testis conserving chemotherapy in germ cell cancer: its potential to increase understanding of the biology and treatment of carcinoma-in-situR T D Oliver, J Ong, D Berney, et al.
Pageof 3